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Escherichia coli YidC is a polytopic inner membrane protein
that plays an essential and versatile role in the biogenesis of
inner membrane proteins. YidC functions in Sec-dependent
membrane insertion but acts also independently as a separate
insertase for certain small membrane proteins. We have used a
site-specific cross-linking approach to show that the conserved
third transmembrane segment of YidC contacts the transmem-
brane domains of both nascent Sec-dependent and -independ-
ent substrates, indicating a generic recognition of insertion
intermediates byYidC.Ourdata suggest that specific residues of
the third YidC transmembrane segment -helix is oriented
toward the transmembrane domains of nascent inner mem-
brane proteins that, in contrast, appear quite flexibly positioned
at this stage in biogenesis.
Approximately 20% of the proteins encoded by the Esche-
richia coli genome are destined for the inner membrane. It is
generally assumed that the Sec-translocon is required for the
insertion ofmost innermembrane proteins (IMPs),2 although a
recent proteomic analysis showed that a defective Sec-translo-
con has surprisingly little effect on the steady state levels of
most IMPs (1). The core of the Sec-translocon consists of the
integral IMPs SecY, SecE, and SecG. SecD, SecF, and YajC form
an accessory complex that facilitates protein insertion and
translocation but is not essential for survival (2, 3). In addi-
tion, the essential IMP YidC was co-purified with the Sec-
translocon (4). YidC has been characterized as an evolution-
ary conserved factor that is involved in the integration of
many IMPs, including those that insert independent from
the Sec-translocon (2, 3).
The exact function of YidC is unknown. Cross-linking stud-
ies have indicated that YidC contacts the transmembrane seg-
ments (TMs) of substrate IMPs upon their lateral exit from the
Sec-translocon to facilitate their integration into the lipid
bilayer (5–7). Recent studies on the biogenesis of CyoA (sub-
unit II of the cytochrome o oxidase) have shown that YidC can
also function upstream of the Sec-translocon in the initial
insertion of theN-terminal region of nascent CyoA followed by
translocation of the (more complex) C-terminal domain by the
Sec-translocon (8–10). Furthermore, YidChas been implicated
in the folding and quality control of Sec-dependent IMPs (5, 7,
11, 12). Strikingly, YidC is also able to function as an insertase
for small proteins such as F0c (the subunit c of F1F0-ATPase)
and M13 and Pf3 phage coat proteins (2, 3).
Little is known about the mechanism and timing of the rec-
ognition of substrate TMs by YidC both in its Sec-dependent
and -independent operational mode. To address directly which
region of YidC is involved in substrate recognition, we have
used an in vitro site-specific cross-linking approach. We have
found that during membrane integration, the TMs of several
tested Sec-dependent and -independent IMPs are adjacent to a
specific region inYidCTM3 that belongs to themost conserved
part of YidC. The TM in the nascent substrate is flexibly ori-
ented toward YidC, both lateral and vertical, whereas YidC
TM3 displays a fixed orientation toward its substrate. We
hypothesize that TM3 is (part of) a generic docking site for
hydrophobic domains in growing nascent IMPs and provides a
protected environment that facilitates their lipid partitioning
and folding.
EXPERIMENTAL PROCEDURES
Enzymes, Reagents, and Sera—Restriction enzymes were
fromRocheApplied Science.Megashortscript T7 transcription
kit was from Ambion Inc. [35S]Methionine was from Amer-
sham Biosciences. Bis-Maleimidoethane (BMOE) and Bis-ma-
leimidohexane (BMH)were fromPierce. Benzophenone-4-ma-
leimide (BPM) was from Molecular Probes. Phenanthroline,
N-ethylmaleimide, and all other chemicals were supplied by
Sigma. Antisera against YidC, PspA, and Lep have been
described previously or were from our own collection (13).
Strains and Plasmids—Strain MC4100 was used to obtain
translation lysate (14). StrainTop10F (Invitrogen)was used for
routine cloning and maintenance of plasmid constructs. Strain
JS7131, in which yidC is under the control of the araBAD oper-
ator/promoter, was used to express YidC cysteinemutants (15).
pCL1921YidC-StrepII-CBP derivatives encoding the YidC cys-
teine mutants were constructed as follows. The coding region
for the calmodulin-binding peptide (CBP) was PCR-amplified
from pCalKC (Stratagene) with a forward primer containing a
SacI restriction site and the Streptavidine tag II sequence and
with a reverse primer containing the EcoRI restriction site
(primer sequences available upon request). The PCR product
was digested with SacI and EcoRI and introduced 3 of the yidC
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gene into pEH1YidC (16), resulting in pEH1YidC-StrepII-CBP.
This plasmid was digested with KpnI and EcoRI, and the
restriction product containing the 3 end of YidC gene with the
StrepII-CBP tag was cloned into the low copy plasmid
pCL1921YidC (17), replacing the 3 end of YidC, resulting in
pCL1921YidC-StrepII-CBP (we will refer to this plasmid as
pCLYidC). The plasmid pCLYidC was used as a template for
constructing single cysteinemutants in the YidC gene using the
QuikChange site-directed mutagenesis kit (Stratagene). First,
the codon for cysteine 423 was changed into an alanine codon
resulting in pCLYidC C423A. This plasmid was subsequently
used as a template to construct further single cysteine mutants
in yidC gene. The nucleotide sequences of the mutant genes
were confirmed by DNA sequencing.
YidC wild type and cysteine derivatives (see Table 1) were
expressed in the YidC depletion strain JS7131 carrying pEH3.
pEH3 encodes the LacI repressor and is used to minimize leak-
age expression from the pCLYidC plasmid. Expression from
pCLYidC was induced by 200 M isopropyl-1-thio--D-galac-
topyranoside. Strains were used to make IMVs for insertion
assays (14). Single cysteine mutants of FtsQ, F0c, and Lep were
constructed in pC4Meth by nested PCR as described previously
(18).
In Vitro Transcription, Translation, Integration, and Cross-
linking—Truncated mRNA was prepared as described previ-
ously (4) from HindIII-linearized pC4Meth derivatives.
Translation and membrane integration of nascent chains
were carried out as described previously (4). Long range cys-
teine cross-linking was carried out with BMOE (1 mM) or
BMH (0.5 mM) for 10 min at 25 °C and quenched with 5 mM
-mercaptoethanol for 10 min on ice. To separate integral
membrane from soluble and peripheral cross-linked com-
plexes, the samples were extracted with 0.18 M Na2CO3 (pH
11.5). The carbonate pellet fractions were analyzed by SDS-
PAGE. Short range cysteine cross-linking was induced with 1
mM Cu2[phenanthroline]2 (CuPhe) for 10 min at 25 °C and
subsequently quenched with 10 mM N-ethylmaleimide for 10
min on ice. CuPhe was prepared as described previously (19),
and the carbonate-resistant fraction was dissolved in SDS sam-
ple buffer without dithiothreitol. For photocross-linking, nas-
cent chains (prepared as described previously (4)) and BPM (1
mM) were incubated for 10 min at 25 °C and quenched with 10
mMN-ethylmaleimide on ice for 10min. Subsequently, the nas-
cent chains were purified through a high salt sucrose cushion
(500 mM KOAc, 500 mM sucrose, 5 mM Mg(OAc)2, 50 mM
Hepes-KOH, pH 7.9) and resuspended in RN buffer (100 mM
KOAc, 5 mM Mg(OAc)2, 50 mM Hepes-KOH, pH 7.9). IMVs
were added to allow targeting and integration into the mem-
brane, and the samples were UV-irradiated to induce cross-
linking to membrane components as described previously (4).
The carbonate pellet fractions were analyzed by SDS-PAGE.
Radiolabeled proteinswere visualized by phosporimaging using
a Molecular Dynamics PhosphorImager 473.
RESULTS
Experimental Strategy—To investigate the interaction of
YidC with nascent IMPs during their insertion into the E. coli
inner membrane, we have cross-linked integration intermedi-
ates in an in vitro approach (4). In this technique, translation of
a truncated mRNA (a mRNA that lacks a stop codon) is trans-
lated in a cell-free E. coli extract to produce nascent, ribosome-
bound polypeptides of predefined length. Translation is carried
out in the presence of [35S]methionine to label the nascent
chains, and IMVs are added to allow co-translational insertion
of the nascent IMP into the Sec/YidC-translocon or YidC inser-
tase. Upon insertion, interactions of the nascent chain and the
translocon/insertase are probed by cross-linking using homo-
bifunctional cysteine specific reagents. Introduction of single
cysteines in both the nascent chain and the interacting partner
protein makes the procedure site-specific. Thus, this approach
yields spatial information regarding the proximity of the inte-
gration intermediate and its partner at the residue level.
The integration intermediates used in this study were
derived from themodel IMPs FtsQ, leader peptidase (Lep), and
the F0c subunit of the F1F0-ATPase. FtsQ is a single spanning,
type II IMP involved in cell division (see Fig. 3A) (20). Lep, the
major signal peptidase, spans the membrane twice with trans-
locatedN andC termini (see Fig. 6A). F0c has the same topology
as Lep but comprises a much shorter translocated C terminus
(Fig. 7A). FtsQ and Lep have been shown to use the Sec/YidC-
translocon for membrane integration (4, 5, 15, 21). In contrast,
F0c only requires the YidC insertase (Fig. 7A) (22–24).
Construction and Characterization of Single Cysteine YidC
Mutants—Using site-specific photo cross-linking, it has been
shown previously that nascent FtsQ is targeted to the Sec-
translocon by the SRP (18). The FtsQ TM inserts initially at
SecY moving to a combined YidC/lipid environment upon
elongation as suggested by sequential contacts during insertion
of nascent FtsQ (6). For instance, a relatively long nascent FtsQ
of 108 amino acids harboring a photo-probe at position 40 in
the TM was shown to primarily cross-link YidC. Furthermore,
108FtsQ with a single cysteine engineered at position 40 was
shown to cross-link YidC reconstituted in proteoliposomes
together with SecYEG using the homo-bifunctional cysteine
specific cross-linker BMOE (8 Å) (25). Because YidC only con-
tains one cysteine at position 423 in the third TM, this obser-
vation implied that TM3 of YidC is close to the TM of nascent
FtsQ at this stage in the integration process. Interestingly, TM3
belongs (together with TM2) to the most conserved regions in
the Oxa1/Alb3/YidC family members (26).
To examine the proximity between YidC TM3/TM2 and
nascent IMPs in more detail, we have used cysteine scanning
cross-linking. First, the single endogenous cysteine in YidCwas
replaced by alanine to generate cysteine-free YidC. This deriv-
ative served as a negative control in our cross-link studies and as
a starting point to introduce single cysteine residues at selected
positions in TM3 and TM2 (Table 1), covering more than two
turns of the presumably -helical TM3 structure and one turn
in TM2 (Fig. 1, B andC). All of the yidC constructs were cloned
in the low copy expression vector pCL1921 under lac promoter
control. To distinguish the plasmid-encoded YidC derivatives
from endogenous YidC, a StrepII-CBP tag was added at the C
terminus of all constructs, increasing the size of YidC by 5
kDa. TaggedYidC that contains the cysteine at position 423will
be further referred to as wild type.
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Functionality of the YidC derivatives was assessed by inves-
tigating their ability to complement the in vivo growth defect
that accompanies depletion of YidC. To this end, the constructs
were introduced in the YidC depletion strain JS7131 in which
expression of the chromosomal yidC is under control of the
araBAD promoter (15). Complementationwas assayed on solid
medium in the absence of L-arabinose to repress the chromo-
somal yidC but in the presence of isopropyl-1-thio--D-galac-
topyranoside to induce expression of the plasmid-encoded
yidC derivative (Fig. 2A). As a control, JS7131 transformedwith
the cloning vector only grew on the plate containing L-arabi-
nose as expected. pCL1921 encoding wild type YidC comple-
mented growth in the absence of L-arabinose, indicating that
YidC with a C-terminal StrepII-CBP tag is functional, consist-
ent with the permissive nature of the C-terminus of YidC with
respect to alterations (16, 27). Importantly, all plasmid-en-
coded single cysteine YidC mutants were able to complement
growth of JS7131 in the absence of L-arabinose, indicating that
they are functional.
For in vitro cross-link experiments, IMVs were prepared of
all JS7131 derivatives grown in liquid LB in the absence of L-
arabinose and the presence of isopropyl-1-thio--D-galactopy-
ranoside to specifically express the plasmid-encoded YidC.
YidCwas detected in the IMVs of all mutants, albeit at different
levels for reasons that are unknown. As expected, the YidC
mutants ran slower in SDS-PAGE compared with untagged
YidC (faintly visible in the empty pCL vector control) (Fig. 2B).
FIGURE 1. Schematic representation of YidC. A, topology model of YidC in
the inner membrane. B, helical representation of YidC TM2 and TM3. C, high-
lightedare the residues thathavebeenchanged to cysteineoneat a time. The
unique endogenous cysteine at position 423 (white on black) has been
changed to alanine in the caseswhere another cysteine is introduced in YidC.
The residues that cross-link to TMs in nascent chains are shown with a black
ring. The thickness of the ring roughly corresponds to the efficiency of
cross-linking.
FIGURE 2. Functionality of YidC cysteinemutants. A, E. coli JS7131 contain-
ing pCLYidC cysteinemutants or empty vectorwere grownon LB agar plates.
The cells were grown under conditions where the chromosomal yidC gene
was induced (0.2% L-arabinose) or where the expression from the plasmid
encoded YidC cysteine mutants was induced by isopropyl-1-thio--D-galac-
topyranoside (200 M). B, Western blot analysis of IMVs containing the YidC
cysteine mutants using antibodies against YidC, PspA, and Lep.
TABLE 1
Plasmids encoding YidC derivatives
Name Plasmid TM2 TM3
pCL pCL
YidC pCL.YidC-StrepII-CBP
C423A pCL.YidC-StrepII-CBP C423A C432A
F356C pCL.YidC-StrepII-CBP C423A/F356C F356C C432A
S357C pCL.YidC-StrepII-CBP C423A/S357C S357C C432A
I358C pCL.YidC-StrepII-CBP C423A/I358C I358C C432A
F424C pCL.YidC-StrepII-CBP C423A/F424C C423A/F424C
P425C pCL.YidC-StrepII-CBP C423A/P425C C423A/P425C
L426C pCL.YidC-StrepII-CBP C423A/L426C C423A/L426C
Q429C pCL.YidC-StrepII-CBP C423A/Q429C C423A/Q429C
M430C pCL.YidC-StrepII-CBP C423A/M430C C423A/M430C
P431C pCL.YidC-StrepII-CBP C423A/P431C C423A/P431C
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We have shown previously that depletion of YidC leads to
up-regulation of PspA, which is in part associated with the
inner membrane (13). PspA is a stress protein that responds to
dissipation of the proton motive force (28). YidC depletion
affects the proton motive force by defects in the functional
assembly of the F1F0-ATPase and the cytochrome o oxidase (13,
29). As shown in Fig. 2B, the induction of PspA seen in the
empty pCL vector control is completely prevented by expres-
sion of all YidC derivatives. This indicates that all of the
mutants are able to sustain the proton motive force and are
functional in the assembly of respiratory chain complexes.
Together, the data suggest that the YidC derivatives, although
for unknown reasons expressed at different levels compared
with the Lep loading control (Fig. 2B), are functional.
The TM of 108FtsQ Inserts in Proximity of YidC TM3—To
probe the environment of the TM in the 108FtsQ integration
intermediate near YidC TM3, 108FtsQCys40 (Fig. 3B) was
inserted in IMVs that contain YidC derivatives with single cys-
teine substitutions in TM3 (Fig. 1C). Upon integration, the
samples were cross-linked using the homo-bifunctional cys-
teine-specific reagent BMOE. Strong and specific cross-linking
was observed to YidC (verified by immunoprecipitation, not
shown) harboring a cysteine at positions 425, 426, 429, or, to a
lesser extent, 424 (Fig. 3C). No adducts were observed in the
absence of BMOE (not shown) or when using IMVs that con-
tain the cysteine-less YidC mutant (Fig. 3C), confirming the
specificity of the procedure.Notably, the positions that strongly
cross-link to 108FtsQCys40 seem to cluster at one side of the
putative -helical YidC TM3, although more positions should
be analyzed to confirm this notion (Fig. 1C).
To rule out that, despite their functionality, some YidC
mutants are structurally altered in such a way that they are no
longer in proximity of nascent 108FtsQCys40, cross-linking
was performed with the hetero-bifunctional reagent BPM.
BPM reacts with the sulfhydryl groups of cysteine residues via a
maleimide moiety. Upon ultraviolet irradiation, a reactive spe-
cies is generated that can form covalent bonds with nearby
groups. The linker arm connecting the two reactive groups is
10 Å. 108FtsQCys40 nascent chains were produced, purified
through a high salt sucrose cushion, and incubatedwithBPMto
allow cross-linking to theCys40 residue. Subsequently, the sam-
ples were incubated with -mercaptoethanol to quench cys-
teine cross-linking. Then IMVswere added formembrane inte-
gration of 108FtsQCys40-BPM, and the samples were
UV-irradiated to induce cross-linking to membrane compo-
nents independent of closely spaced cysteine residues. By this
procedure, all of the YidC derivatives were cross-linked to the
FtsQ integration intermediate (Fig. 3D). In this and the follow-
ing experiments, no YidC cross-linking adducts were observed
in the absence of cross-linkers (data not shown). This shows
that the IMVs with the YidC derivatives are still functional in
accommodating nascent 108FtsQCys40 in accordance with the
in vivo complementation data described above.
The TM of 108FtsQ Is Dynamically Oriented Relative to YidC
TM3—To obtain more spatial and structural information
regarding the proximity of the TM in 108FtsQ and YidC TM3,
four additional mutants were constructed that have single cys-
teines in the TM of 108FtsQ at positions 36, 39, 41, and 42 (Fig.
3B). These mutant nascent chains were integrated in the IMVs
that contain YidC derivatives with single cysteine substitutions
in TM3 (Fig. 1C) and cross-linked with BMOE. Interestingly,
the cross-link patterns are very similar to that of 108FtsQCys40,
i.e. cross-linking to YidC positions 425, 426, 429, and, to a lesser
extent, 424 (Fig. 4A). Cross-linking is most efficient at position
425 except for 108FtsQCys36 where cross-linking peaks at
position 426.
The similarity in cross-linking profiles for all of the tested
positions in the TM of 108FtsQ indicates that the FtsQ TM
does not occupy a fixed position relative to YidC TM3. Rather,
the FtsQ TM seems to orient itself flexibly along the more rigid
YidCTM3perpendicular to the plane of themembrane. Impor-
tantly, the analyzed region of the FtsQ TM did not show a clear
helical asymmetry in cross-linking to YidC TM3. This could
mean that the TM in the FtsQ integration intermediate has not
yet adopted an -helical conformation but rather constitutes a
randomly coiled stretch of residues that is able to reposition up
and down relative to YidC TM3. Alternatively, the FtsQ TM is
-helical at this stage, but the helix has sufficient flexibility and
space to rotate relative to YidC TM3. Finally, it cannot be
excluded that the YidC TM3 docking site may have some
mobility toward its substrate.
FIGURE 3.TheTMof 108FtsQ inserts inproximity of YidCTM3.A, topology
model of FtsQ in the inner membrane. B, schematic representation of the
nascent FtsQ derivatives used in this study. The white dot indicates the posi-
tionof theunique cysteine innascent FtsQ, and theblack rectangle represents
the TM. C, nascent 108FtsQCys40 was synthesized in vitro, inserted in IMVs
containing YidCwith single cysteines in TM3, and cross-linked using BMOEor
BPM.D, carbonate-resistantpellet fractions are shown. Thenascent chains are
indicated by asterisks, and the positions of YidC cross-linking adducts are
indicated by brackets.
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To verify that in this approach cross-linking to YidC TM3 is
specific for the TM of 108FtsQ, single cysteines were intro-
duced at positions 15 and 60 located in hydrophilic regions that
flank the FtsQ TM. As expected, BMOE cross-linking yielded
no YidC adducts (supplemental Fig. S1), consistent with previ-
ous photo cross-link data in which probes engineered at posi-
tions 10 and 59 of 108FtsQ did not show significant cross-link-
ing to any region of YidC (4). Together, the data indicate that
the TM of membrane-integrated 108FtsQ contacts YidC TM3
with a high degree of conformational freedom.
The TM of 108FtsQ Is Held at YidC TM3 during Membrane
Integration—Next, we examined the effect of nascent chain
length on the proximity between the FtsQ TM and YidC TM3.
Previously, we have shown by photo cross-linking that the FtsQ
TM in nascent chains as short as 97 residues contacts YidC (6).
With our set of YidC cysteine mutants, we were now able to
specifically examine the effect of nascent chain length on the
interaction of the FtsQ TM with YidC TM3. Remarkably,
97FtsQCys40 integrated in the single cysteine YidC IMVs
showed a BMOE cross-linking profile (Fig. 4B) almost identical
to 108FtsQCys40 (Fig. 3C). These results suggest that the FtsQ
TM, although flexibly oriented towardYidCTM3, is held at this
position for at least some time during elongation and mem-
brane integration. Although more lengths need to be analyzed
to draw more definite conclusions, the data argue against a
strictly linear insertion process in which the TM in the growing
nascent chain slides through the Sec-translocon andYidCon its
way into the lipid bilayer.
Close Proximity of Cysteine Residues in the TM in 108FtsQ to
Specific Positions in YidC TM3—The previous experiments
have shown that BMOE (spacer length of 8 Å) cross-links a
cysteine introduced at position 40 in the TM of the 108FtsQ to
cysteines placed at specific positions in YidC TM3. To examine
the proximity between the cysteines in more detail, we used
CuPhe.CuPhe forms a disulfide cross-link under oxidizing con-
ditions between two cysteines provided that the -carbons of
the two residues are in close proximity (about 4 Å or less).
Strikingly, the cross-link patterns obtained with CuPhe for
108FtsQCys40 (Fig. 5A) are very similar to those obtained with
BMOE, i.e. cross-linking toYidCpositions 425, 426, 429, and, to
a lesser extent, 424 (Figs. 3C and 4A). This confirms the flexible
and, at least temporarily, very close positioning of the TM in
nascent 108FtsQ relative to specific residues in YidC TM3.
It is conceivable that the inability to cross-link 108FtsQ-
Cys40 to some positions in YidC TM3 is due to the short cross-
linking span of BMOE. To examine this possibility, the homo-
bifunctional cysteine cross-linker BMH (16.1 Å) was used. The
results showed a similar cross-linking profile as with BMOE
(Fig. 5B). No other tested positions in YidC TM3 came in reach
of 108FtsQCys40. Taken together, these data suggest a rigid
and confined substrate contact area in YidC TM3.
YidC TM3 Is Also Close to Lep (Sec-dependent) and F0c (Sec-
independent) Integration Intermediates—To investigatewheth-
er the proximity of the TM3 in YidC to the TM in FtsQ reflects
a generic involvement of TM3 in substrate recognition and
binding, we have analyzed the contacts of a Lep integration
intermediate using cysteine cross-linking (Fig. 6B). Lep is a clas-
sical model IMP for Sec-dependent membrane insertion (30).
Previous photo cross-linking studies have revealed that nascent
Lep inserts at the Sec/YidC-translocon (5, 21, 31). In contrast to
FtsQ (6), Lep is synthesized with a reverse signal anchor
sequence (TM1) that is proximal to YidC at a very early stage in
biogenesis approximately simultaneouswith its earliest contact
with SecY (5, 31).Nascent Lep of 50 or 72 residueswith a photo-
probe at position 10 in TM1 cross-linked efficiently and almost
FIGURE 4. The TM of 108FtsQ is flexibly oriented toward YidC TM3 and
held at in this position during protein elongation. In vitro translation of
nascent FtsQ was carried out in the presence of IMVs containing YidC TM3
cysteine mutants and cross-linked using BMOE. Carbonate-resistant pellet
fractions are shown. A, nascent 108FtsQwith a single cysteine in the FtsQ TM
at positions 36, 39, 41, or 42. B, nascent 97FtsQ with a single cysteine at posi-
tion 40 in the TM.
FIGURE 5. Close proximity of 108FtsQ TM to specific positions in YidC
TM3. In vitro translationof nascent 108FtsQwas carriedout in thepresenceof
IMVs containing YidC TM3 cysteine mutants and were cross-linked using dif-
ferent cross-linkers. Carbonate-resistant pellet fractions are shown. A, nas-
cent 108FtsQ with a single cysteine in the FtsQ TM at positions 36, 39, 40, 41,
or 42 were cross-linked with the oxidizing agent CuPhe. B, nascent 108FtsQ-
Cys40 was cross-linked with BMH.
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exclusively toYidC (5). To studywhether these contacts involve
YidC TM3, a single cysteine was introduced at position 10 in a
60Lep construct and analyzed by BMOE cross-linking upon
integration in the IMVs containing the single cysteine substitu-
tions in TM3. Although less focused than the cross-link profile
of FtsQ, cross-linking to YidC TM3 is evident and most effi-
cient to positions 425 and 426, consistent with the FtsQ data
(Fig. 6C).
To examine whether TM3 of YidC is also adjacent to the first
TM of a Sec-independent integration intermediate, we have
used F0c as a model protein. F0c, the c subunit of the F1F0
ATPase, is a small double spanning IMP that is thought to
insert via the YidC-only pathway (22–24) (Fig. 7A). Conse-
quently, nascent 79F0c, with a photo cross-link probe at posi-
tion 15 in its first TM has been shown to almost exclusively
cross-link YidC (24). Here, we introduced a single cysteine at
this position and cross-linked nascent 79F0cCys15 (Fig. 7B)
upon integration in IMVs containing the single cysteine substi-
tutions in YidC TM3. Again, significant cross-linking to resi-
dues 424, 425, 426, and 429 was evident (Fig. 7C). However, in
contrast to nascent FtsQ and Lep, the 79F0cCys15 integration
intermediate showed the most pronounced cross-linking to
residue 429, indicative of a slightly shifted binding optimum.
Together these data suggest that TM3 in YidC constitutes or
participates in a “general docking site” for TMs in both Sec-de-
pendent and Sec-independent nascent IMPs.
Cross-linking of YidC TM2 Cysteine Mutants—The previous
data indicate that YidC TM3 is an important contact site for
inserting nascent IMPs. Like TM3, TM2 is strongly conserved
and cannot be replaced by an unrelated TM (27). To investigate
whether TM2 also contributes to a docking site for TMs of
nascent IMPs, single cysteines were introduced at positions
356, 357, and 358 that are expected to cover one helical turn
near the center of TM2 (Fig. 1B). IMVs derived from cells
expressing these YidC derivatives were subjected to BMOE
cross-linking after integration of 108FtsQCys40, 60LepCys10,
or 79F0cCys15. 108FtsQCys40 did not show significant cross-
linking to the TM2 positions tested (supplemental Fig. S2).
Cross-linking with the Cys-UV cross-linker BMP yielded YidC
adducts in all cases, confirming that YidC in these membranes
is in contact with 108FtsQCys40 (results not shown). Similarly,
FIGURE 6. Lep cross-linking to YidC TM3 cysteine mutants. A, topology of
Lep in the innermembrane. B, nascent Lep derivatives used in this study. The
white circle represents the position of the unique cysteine at position 10 in
nascent Lep. The black rectangle represents the TM. C, in vitro translation of
nascent 60LepCys10 was carried out in the presence of IMVs containing YidC
TM3 cysteinemutants and cross-linked using BMOE. Carbonate-resistant pel-
let fractions are shown.
FIGURE 7. F0c cross-linking to YidC TM3 cysteine mutants. A, topology of
F0c in the IM. B, nascent F0c derivatives used in this study. The white circle
represents the position of the unique cysteine at position 15 in nascent F0c.
The black rectangle represents the TM. C, in vitro translation of nascent
79F0cCys15 was carried out in the presence of IMVs containing YidC TM3
cysteine mutants and cross-linked using BMOE. Carbonate-resistant pellet
fractions are shown.
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60LepCys10 and 79F0cCys15 showed virtually no cross-linking
to YidC TM2 with the exception of position 356, which is
weakly cross-linked to 79F0cCys15 (compare supplemental Fig.
S2 with Figs. 6C and 7C, respectively). Although we cannot
exclude the possibility that other regions in TM2 contribute to
the contact with nascent integration intermediates, the com-
bined data suggest that TM3 is the primary contact site for
newly synthesized TMs.
DISCUSSION
In this paper we show that the conserved TM3 of YidC is
adjacent to the first TM in IMPs during their integration into
the membrane. Although more positions in both YidC and its
substrates need to be analyzed, the data indicate that specific
residues in the TM3 helix are rigidly oriented toward the sub-
strate TM. In contrast, the TM of the nascent IMP appears to
have some freedom of movement relative to YidC TM3. The
TM of the IMP may occupy the contact site at YidC during
synthesis until it is displaced into the lipid bilayer. A key ele-
ment of our analysis is that the TMs in both Sec-dependent and
Sec-independent substrates contact the same region in YidC
TM3, suggesting a universal mechanism of substrate recogni-
tion by YidC.
YidC is an essential E. coli protein that has been cross-linked
to nascent Sec-dependent and -independent IMPs, suggesting a
generic role in the biogenesis of IMPs (2, 3). Functional studies
demonstrated a key role for YidC in the insertion, folding, and
quality control of IMPs (2, 3). Yet little structural information is
available about YidC. The crystal structure of the major
periplasmic domain in between TM1 andTM2 has been solved
recently, but this domain is almost entirely dispensable for
the insertase function (32, 33). Furthermore, a low resolu-
tion electron cryo-microscopy image of the native YidC pro-
tein has been presented but provides too little detail to offer
mechanistic insight (34). In contrast, the structure of the Sec-
translocon has been elucidated at relatively high resolution (3.2
Å), revealing a pore primarily embraced by two arms of SecY
formedbyTM1–5 andTM6–10 (35). It has beenproposed, also
based on biochemical evidence (36), that TMs leave the trans-
locon laterally near TM2 and TM7 to become embedded in the
lipid bilayer (35). It has also been proposed that accessory fac-
tors that assist in this process, such as YidC in bacteria and
TRAM in eukaryotes, are located at this lateral gate to receive
the TMs and transfer them in the right conformation into the
lipids (2, 3, 37, 38).
Following this reasoning, our cross-link data using stalled
integration intermediates indicate that YidC TM3 is oriented
toward the lateral exit of the Sec-translocon, providing a hydro-
phobic interaction face that may facilitate the transfer of
incoming TMs into the lipid bilayer. The “hot spot” for cross-
linking is located at positions 425 and 426.Notably, this is a very
conserved region in YidC and close to the G422R, C423R, and
F424R mutations that confer a cold-sensitive phenotype (39).
We cannot exclude the possibility that other regions in YidC
contribute to substrate binding.Mutagenesis experiments have
revealed that TM2, 3, and 6 are important for viability and func-
tioning of YidC, although there is a remarkable tolerance
toward single amino acid substitutions even at conserved resi-
dues (27). Interestingly, T362E in TM2 was isolated as a sup-
pressor of C423R, pointing to an interaction between TM3 and
TM2 (39). In our study, using cysteine cross-linking, we did not
observe proximity of TM2 toward substrate TMs.
All of the tested cysteine substitutions in the TM of 108FtsQ
show similar cross-linking to the single cysteine mutants of
YidC TM3. This could indicate that at this stage in biogenesis,
the substrate TM has not yet adopted an -helical conforma-
tion. However, using fluorescence resonance energy transfer, it
has been shown that the TM in a eukaryotic nascentmembrane
protein folds into a compact, presumably -helical conforma-
tion already before reaching the Sec61 complex in the endo-
plasmic reticulum (40). It should also be noted in this context
that previous photo cross-linking data (4) hinted at a periodic
interaction between the FtsQ TM and YidC. However, because
of the aspecific nature of the photoprobe, cross-linking to
regions of YidC other than the target TM3 could not be
excluded. Alternatively, the TMof FtsQ is-helical at this stage
but has some rotational freedom. A more speculative interpre-
tation would be that YidC TM3 acts as a scaffold during mem-
brane insertion of IMPs where TMs can fold into an -helix
prior to partitioning into the lipid bilayer. In any case, the effi-
cient cross-linking of different FtsQ TM cysteine mutants with
even short distance cross-linkers suggests a degree of lateral
and vertical movement consistent with the fact that YidC inter-
acts with a variety of substrate TMs with no apparent sequence
similarity.
We have shown previously that the FtsQ TM interacts
sequentially with SecY and YidC during membrane insertion
(6). Interactions with YidCwere already observed at 87–97 res-
idues nascent chain length. Strikingly, the TMof 97FtsQ shows
very similar cross-linking profiles as the TM of 108FtsQ, argu-
ing that the TM is held for some time at YidCTM3before being
released into the lipids. Similarly, TM2 of nascent Lep has been
shown to remain near YidC during elongation of 40–60 amino
acids prior to release into the lipids (5). The extent and duration
of the contact with YidCmay depend on the characteristics and
context of the individual TM in the substrate nascent chain.
The first three TMs in the polytopic membrane proteins MtlA
(7) and MalF (41) have been shown to contact YidC simulta-
neously, suggesting that YidC also functions as a platform for
the assembly of complex IMPs. Possibly, YidC TM3 functions
in the initial recognition of substrate TMs before relocating
them for folding and assembly to other regions in YidC that
remain to be determined.
YidC TM3 seems to act as a generic docking site for TMs in
substrate nascent IMPs. The first TM in nascent Lep that, in
contrast to the FtsQ TM, has a N-out orientation in the native
protein, is also cross-linked to YidC TM3 during membrane
insertion, albeit with a slightly shifted cross-linking optimum.
More strikingly, YidC TM3 is cross-linked to the first TM of
nascent F0c that inserts independent from the Sec-translocon
in the YidC insertase. This implies that the initial recognition of
substrateTMsbyYidCmay be similar regardless ofwhether the
substrate is approaching YidC from the Sec-translocon or
directly from the cytosol. Although speculative, YidC might
facilitate transfer of TMs from the interior of the Sec-translo-
con or the cytosol by a similar mechanism. Using photo cross-
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linking, we have shown previously that the TM in nascent
108FtsQ shows simultaneous contacts with both YidC and lip-
ids, suggesting that interaction may take place at a YidC-lipid
interface (6). A comparable interface may be used by Sec-inde-
pendent IMPs to facilitate insertion of their TM(s) into the
membrane lipids concomitant with the translocation of small
adjacent periplasmic domains. More detailed mechanistic
insight will benefit from structural information on the con-
served membrane-embedded domain of YidC purified in asso-
ciation with the Sec-translocon or as a separate entity prefera-
bly bound to a stalled nascent substrate IMP.
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